Washington [US], January 30 (ANI): Neurofeedback, also called 'brain training' may be an effective treatment for individuals with post-traumatic stress disorder (PTSD), suggests a new study.
Washington [US], January 30 (ANI): A new research suggests that minocycline, an antibiotic with anti-inflammatory properties, improves depressive symptoms in patients with low-grade peripheral inflammation.
Washington [US], January 30 (ANI): Teenagers with happy childhood memories are likely to drink less, consume fewer drugs, and enjoy learning, suggest the findings of a new study.
London [UK], January 30 (ANI): A new study suggested how certain types of bacteria can change their shape in order to adapt to long-term exposure to antibiotics.
London [UK], January 29 (ANI): Four million UK patients could benefit annually from genetic testing before being prescribed common medicines, according to new research.
Washington [US], January 29 (ANI): A new nationally representative study led by researchers at Nationwide Children's Hospital, has found poor-quality housing is independently associated with poorer pediatric health and suggests ways health care providers and housing programs may address the
Washington [US], January 28 (ANI): While antibiotics are widely used to treat bacterial infections and other illnesses, a new research suggested that minocycline, an antibiotic with anti-inflammatory properties, improved depressive symptoms in patients with low-grade peripheral inflammation.
Thiruvananthapuram (Kerala) [India], January 27 (ANI): Industry leaders Ratan Tata, Anand Mahindra and Nobel Laureate Amartya Sen are among an impressive line-up of speakers expected to share their insights and suggestions at 'Kerala Looks Ahead' (KLA) global meet.
Washington [US], January 27 (ANI): A new study suggested that Neurofeedback, also called 'brain training' may be an effective treatment for individuals with post-traumatic stress disorder (PTSD).
Columbus [US], January 26 (ANI): There could be an intervention on the horizon to help prevent heart damage caused by the common chemotherapy drug doxorubicin, new research suggests.